^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PVT-1

    i
    Other names: PVT-1
    Associations

    News

    Trials
    Company:
    PlusVitech
    Drug class:
    Apoptosis stimulant
    Related drugs:
    Associations

    News

    Trials
    over1year
    Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer (clinicaltrials.gov)
    P2, N=24, Recruiting, PlusVitech S.L. | Trial completion date: Dec 2022 --> Dec 2025 | Trial primary completion date: Dec 2022 --> Dec 2025
    Trial completion date • Trial primary completion date • Metastases
    |
    EGFR (Epidermal growth factor receptor) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
    |
    PVT-1